Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed director
Quarterly results
Acq. announced

ANI PHARMACEUTICALS INC (ANIP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Gassert Chad (SVP - CORP. DEV. & STRATEGY) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 20,000 shares @ $56.48, valued at $1.1M
08/25/2023 4 Gutwerg Ori (SVP, GENERICS) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 13,502 shares @ $62.39, valued at $842.4k
Sold 2,059 shares @ $62.39, valued at $128.5k
Exercised 13,502 options to buy @ $31.49, valued at $425.2k
08/25/2023 4 Marken James G. (SVP OPS & PROD DEV) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 3,932 shares @ $63, valued at $247.7k
Exercised 3,750 options to buy @ $40.59, valued at $152.2k
Exercised 1,667 options to buy @ $33, valued at $55k
08/23/2023 4 Leonard Matthew J (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 7,583 shares @ $0
08/16/2023 4 MERIDIAN VENTURE PARTNERS II LP (10% Owner) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 200,000 shares @ $58.5, valued at $11.7M
08/16/2023 4 Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 27,890 shares @ $61.15, valued at $1.7M
Sold 22,110 shares @ $61.6, valued at $1.4M
08/16/2023 4 CAREY STEPHEN P. (SVP & CFO) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 17,639 shares @ $61.37, valued at $1.1M
08/15/2023 4 Pera Antonio R (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 3,000 shares @ $60.37, valued at $181.1k
08/15/2023 4 Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 56,666 shares @ $57.75, valued at $3.3M
Sold 11,616 shares @ $61.13, valued at $710.1k
Exercised 11,616 options to buy @ $29, valued at $336.9k
08/03/2023 4 Gassert Chad (SVP - CORP. DEV. & STRATEGY) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 20,000 shares @ $51.06, valued at $1M
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2023 4 Gassert Chad (SVP - CORP. DEV. & STRATEGY) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Sold 20,000 shares @ $53.43, valued at $1.1M
05/24/2023 4 TANNENBAUM RENEE P (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 6,865 shares @ $0
05/24/2023 4 Walsh Patrick D (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 6,865 shares @ $0
05/24/2023 4 Thoma Jeanne (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 6,865 shares @ $0
05/24/2023 4 Pera Antonio R (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 6,865 shares @ $0
05/24/2023 4 NASH DAVID (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 6,865 shares @ $0
05/24/2023 4 HAUGHEY THOMAS (Director) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 6,865 shares @ $0
04/04/2023 4 Lalwani Nikhil (PRESIDENT & CEO) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 95,530 shares @ $0
Granted 63,686 shares @ $0
04/04/2023 4 Shanmugam Muthusamy (HEAD OF R&D, COO-NOVITIUM OPS) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 17,369 shares @ $0
Granted 11,578 shares @ $0
04/04/2023 4 Mutz Christopher (HEAD OF RARE DISEASE) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 17,369 shares @ $0
Granted 11,578 shares @ $0
04/04/2023 4 Marken James G. (SVP OPS & PROD DEV) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 13,026 shares @ $0
Granted 8,684 shares @ $0
04/04/2023 4 Gutwerg Ori (SVP, GENERICS) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 17,369 shares @ $0
Granted 11,578 shares @ $0
04/04/2023 4 Gassert Chad (SVP - CORP. DEV. & STRATEGY) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 17,369 shares @ $0
Granted 11,578 shares @ $0
04/04/2023 4 Davis Krista (SVP, CHIEF HR OFFICER) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 12,158 shares @ $0
Granted 8,104 shares @ $0
04/04/2023 4 Cook Meredith (SR. VP, GENERAL COUNSEL & SEC.) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Granted 12,158 shares @ $0
Granted 8,104 shares @ $0
03/30/2023 4 Marken James G. (SVP OPS & PROD DEV) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 524 shares @ $38.62, valued at $20.2k
03/30/2023 4 CAREY STEPHEN P. (SVP AND CFO) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,420 shares @ $38.62, valued at $54.8k
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/09/2023 4 Mutz Christopher (HEAD OF RARE DISEASE) has filed a Form 4 on ANI PHARMACEUTICALS INC
Txns: Paid exercise price by delivering 1,426 shares @ $44.23, valued at $63.1k
Paid exercise price by delivering 476 shares @ $44.23, valued at $21.1k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy